We traced the spatial distribution of these nonsynonymous mutations and observed that although KRAS and S100A11 were expressed in various regions, the mutated gene form was mainly restricted in the tumor regions (Fig. 6F, Supplementary Fig. S8A), suggesting potential neoantigens. Here, S100A11 is linked to neoplasm.